Home > Insider Trading > Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc. (IOVA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

10 Most Promising Cancer Stocks According to Hedge Funds

According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in six deaths worldwide.

Keep Reading →

November 22nd, 2024 - Hedge Funds Industries News

12 NASDAQ Stocks with Biggest Upside Potential According to Analysts

Potomac Wealth Advisors president Mark Avallone joined CNBC's 'The Exchange' on November 16 to discuss where he sees investing opportunities following Trump's election.

Keep Reading →

November 21st, 2024 - Hedge Funds News

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript November 7, 2024Iovance Biotherapeutics, Inc. beats earnings expectations.

Keep Reading →

November 9th, 2024 - News Transcripts

8 Most Promising Stocks to Buy According to Wall Street Analysts

With only a few days left until the 2024 presidential election, investors are preparing for potential volatility to shake the stock market.

Keep Reading →

October 15th, 2024 - Hedge Funds News

10 Best Biotech Stocks To Buy Under $20

The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.

Keep Reading →

October 6th, 2024 - Hedge Funds News

10 Stocks Under $10 With High Potential

There has been ongoing geopolitical in the Middle East, which escalated recently when Iran launched a series of missiles toward Israel.

Keep Reading →

October 3rd, 2024 - Hedge Funds News

10 Worst Cancer Stocks To Buy Now According to Short Sellers

Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one of the largest sectors in the life sciences.

Keep Reading →

September 11th, 2024 - Hedge Funds Industries News

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2024 Earnings Call Transcript

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2024 Earnings Call Transcript August 8, 2024Iovance Biotherapeutics, Inc. beats earnings expectations.

Keep Reading →

August 9th, 2024 - News Transcripts

Here’s Why Iovance Biotherapeutics (IOVA) Declined in Q2

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

July 29th, 2024 - Hedge Fund Investor Letters News